Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Am J Med Genet A ; 179(1): 20-28, 2019 01.
Article in English | MEDLINE | ID: mdl-30569628

ABSTRACT

Several countries, as Brazil, have public policies for periconceptional folic acid supplementation (FAS) in order to prevent unfavorable outcomes. Our aim was to evaluate the FAS situation in a public reference hospital from Southern Brazil. This study included all mothers who had children born at the Hospital Materno Infantil Presidente Vargas, RS, Brazil, in a 1-year period. Data collection was conducted through interviews with application of a clinical protocol and analysis of the patients' records. FAS was defined as the use of folic acid in any period of the periconceptional period, irrespective of the duration and amount. We also classified those mothers who correctly followed the national recommendation proposed by the Health Ministry of Brazil. The sample consisted of 765 mothers evaluated soon after childbirth. Their ages ranged from 12 to 45 years (mean 25.2 years). The overall level of FAS was 51.5%, and the use according to the national recommendation occurred in only 1.6%. Factors associated with non-FAS consisted of lower maternal age (p = .009) and maternal schooling (p = .023), higher number of pregnancies (p = .003), fewer prenatal visits (p = .050) and later prenatal care onset (p = .037). Periconceptional FAS in our midst seems to be very far from the ideal goal. Susceptible groups appeared to be mothers who were younger, less educated, multiparous, and had inadequate prenatal care. We believe that efforts of education and awareness should be especially targeted for these groups. These recommendations should also be strengthened among those who prescribe the FAS.


Subject(s)
Dietary Supplements , Folic Acid/administration & dosage , Neural Tube Defects/diet therapy , Prenatal Care , Adolescent , Adult , Brazil/epidemiology , Child , Female , Humans , Middle Aged , Neural Tube Defects/epidemiology , Neural Tube Defects/prevention & control , Pregnancy , Young Adult
4.
Birth Defects Res A Clin Mol Teratol ; 106(4): 225-31, 2016 Apr.
Article in English | MEDLINE | ID: mdl-26932830

ABSTRACT

BACKGROUND: Nasoethmoidal meningocele is considered an uncommon type of cephalocele, and congenital cystic adenomatoid malformation (CCAM) is a rare lung disorder characterized by overgrowth of the terminal bronchioles. CASE: We report the unusual association between a nasoethmoidal meningocele and CCAM type II in a fetus exposed to valproic acid and misoprostol. The mother was an 18-year-old woman on her first pregnancy. She had a history of absence seizures since she was 5 years old. She took valproic acid from the beginning of the gestation until the end of the third month. At the end of the third month, she attempted interruption of her pregnancy using misoprostol. The fetal nasoethmoidal meningocele and CCAM type II were identified through morphological ultrasound examination and magnetic resonance imaging. A genome-wide study detected one copy number variation classified as rare, entirely contained into the SPATA5 gene. However, it does not seem to be associated to the clinical findings of the patient. CONCLUSION: To our knowledge, there is only one case reported in the literature showing the same association between a nasoethmoidal meningocele and CCAM. Thus, the malformations observed in our patient may be related to the gestational exposures. Also, we cannot rule out that the patient may present the same condition characterized by a cephalocele and CCAM described by some authors, or even an undescribed entity, because some hallmark features, such as laryngeal atresia and limb defects, were not observed in our case. Further reports will be very important to better understand the associations described in our study.


Subject(s)
Cystic Adenomatoid Malformation of Lung, Congenital , Fetal Diseases , Homeodomain Proteins/genetics , Meningocele , Misoprostol/adverse effects , Valproic Acid/adverse effects , ATPases Associated with Diverse Cellular Activities , Adolescent , Cystic Adenomatoid Malformation of Lung, Congenital/chemically induced , Cystic Adenomatoid Malformation of Lung, Congenital/diagnostic imaging , Cystic Adenomatoid Malformation of Lung, Congenital/genetics , Female , Fetal Diseases/chemically induced , Fetal Diseases/diagnostic imaging , Fetal Diseases/genetics , Genome-Wide Association Study , Humans , Magnetic Resonance Imaging , Meningocele/chemically induced , Meningocele/diagnostic imaging , Meningocele/genetics , Misoprostol/administration & dosage , Pregnancy , Valproic Acid/administration & dosage
5.
Am J Med Genet A ; 167(6): 1294-9, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25899236

ABSTRACT

Warfarin is a synthetic oral anticoagulant that crosses the placenta and can lead to a number of congenital abnormalities known as fetal warfarin syndrome. Our aim is to report on the follow-up from birth to age 8 years of a patient with fetal warfarin syndrome. He presented significant respiratory dysfunction, as well as dental and speech and language complications. The patient was the second child of a mother who took warfarin during pregnancy due to a metallic heart valve. The patient had respiratory dysfunction at birth. On physical examination, he had a hypoplastic nose, pectus excavatum, and clubbing of the fingers. Nasal fibrobronchoscopy showed upper airway obstruction due to narrowing of the nasal cavities. He underwent surgical correction with Max Pereira graft, zetaplasty, and osteotomies for the piriform aperture. At dental evaluation, he had caries and delayed eruption of the upper incisors. Speech and language assessment revealed high palate, mouth breathing, little nasal patency, and shortened upper lip. Auditory long latency and cognitive-related potential to auditory stimuli demonstrated functional changes in the cortical auditory pathways. We believe that the frequency of certain findings observed in our patient may be higher in fetal warfarin syndrome than is appreciated, since a significant number result in abortions, stillbirths, or children evaluated in the first year of life without a follow-up. Thus, a multidisciplinary approach and long-term monitoring of these patients may be necessary.


Subject(s)
Abnormalities, Drug-Induced/pathology , Auditory Perceptual Disorders/pathology , Nasal Bone/abnormalities , Nasal Obstruction/pathology , Prenatal Exposure Delayed Effects/pathology , Tooth Abnormalities/pathology , Warfarin/adverse effects , Abnormalities, Drug-Induced/genetics , Abnormalities, Drug-Induced/surgery , Auditory Perceptual Disorders/chemically induced , Auditory Perceptual Disorders/genetics , Auditory Perceptual Disorders/surgery , Child , Female , Fetus , Follow-Up Studies , Humans , Male , Mothers , Nasal Bone/pathology , Nasal Bone/surgery , Nasal Obstruction/chemically induced , Nasal Obstruction/genetics , Nasal Obstruction/surgery , Osteotomy , Pregnancy , Prenatal Exposure Delayed Effects/chemically induced , Prenatal Exposure Delayed Effects/genetics , Prenatal Exposure Delayed Effects/surgery , Tooth Abnormalities/chemically induced , Tooth Abnormalities/genetics , Tooth Abnormalities/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...